FIIs holdings in pharmaceutical company have increased to 28.8% in March 2013 quarter from 27.76% at the end of December 2012 quarter, the shareholding pattern data shows. FIIs held 27.99% stake in September quarter.
Overseas investors have increased their holdings in the company by over one percentage points during the recently concluded quarter. FIIs have bought 4.66 million shares worth of Rs 279 crore in January-March quarter.
The stock opened at Rs 648 and hit a low of Rs 642 in early morning deals on NSE. A combined 264,928 shares have changed hands on the counter till 1010 hours against an average sub 750,000 shares that were traded daily in past ten trading days on NSE and BSE.
Meanwhile, the stock has outperformed the market by surging 8% so far in current calendar year 2013 compared to 6.4% fall in benchmark Nifty.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
